| Year |
Citation |
Score |
| 2022 |
Matsiukevich D, House SL, Weinheimer C, Kovacs A, Ornitz DM. Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injury. Frontiers in Cardiovascular Medicine. 9: 1011167. PMID 36211556 DOI: 10.3389/fcvm.2022.1011167 |
0.43 |
|
| 2016 |
House SL, Castro AM, Lupu TS, Weinheimer C, Smith C, Kovacs A, Ornitz DM. Endothelial Fibroblast Growth Factor Receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00758.2015. PMID 26747503 DOI: 10.1152/Ajpheart.00758.2015 |
0.427 |
|
| 2015 |
House SL, Wang J, Castro AM, Weinheimer C, Kovacs A, Ornitz DM. Fibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injury. Physiological Reports. 3. PMID 25626875 DOI: 10.14814/Phy2.12278 |
0.565 |
|
| 2013 |
Cilvik SN, Wang JI, Lavine KJ, Uchida K, Castro A, Gierasch CM, Weinheimer CJ, House SL, Kovacs A, Nichols CG, Ornitz DM. Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy. Plos One. 8: e82979. PMID 24349409 DOI: 10.1371/Journal.Pone.0082979 |
0.472 |
|
| 2012 |
Manning JR, Carpenter G, Porter DR, House SL, Pietras DA, Doetschman T, Schultz Jel J. Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels. Growth Factors (Chur, Switzerland). 30: 124-39. PMID 22304432 DOI: 10.3109/08977194.2012.656759 |
0.423 |
|
| 2011 |
House S, Weinheimer C, Kovacs A, Ornitz D. 187 EMFEndogenous Fibroblast Growth Factor 2 Protects the Heart in a Murine Model of Closed Chest Regional Ischemia-Reperfusion Injury Annals of Emergency Medicine. 58: S240. DOI: 10.1016/J.Annemergmed.2011.06.215 |
0.431 |
|
| 2010 |
House SL, House BE, Glascock B, Kimball T, Nusayr E, Schultz JE, Doetschman T. Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase. Molecular and Cellular Pharmacology. 2: 143-154. PMID 21274419 DOI: 10.4255/Mcpharmacol.10.20 |
0.544 |
|
| 2010 |
House SL, Newman G, Schultz JJ. 14 EMF: Human Recombinant Low Molecular Weight Fibroblast Growth Factor 2 Protects the Heart From Reperfusion Injury Through Activation of FGF Receptors and Nitric Oxide Signaling Annals of Emergency Medicine. 56. DOI: 10.1016/J.Annemergmed.2010.06.040 |
0.453 |
|
| 2007 |
House SL, Melhorn SJ, Newman G, Doetschman T, Schultz Jel J. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2. American Journal of Physiology. Heart and Circulatory Physiology. 293: H354-65. PMID 17337596 DOI: 10.1152/Ajpheart.00804.2006 |
0.514 |
|
| 2005 |
House SL, Branch K, Newman G, Doetschman T, Schultz Jel J. Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade. American Journal of Physiology. Heart and Circulatory Physiology. 289: H2167-75. PMID 16040717 DOI: 10.1152/Ajpheart.00392.2005 |
0.603 |
|
| 2003 |
House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, Schultz Jel J. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation. 108: 3140-8. PMID 14656920 DOI: 10.1161/01.Cir.0000105723.91637.1C |
0.446 |
|
| Show low-probability matches. |